Rapid Benzodiazepine Detoxification Using Flumazenil - 1

• Status: Completed
• Trial end date: 1994-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yale University
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Flumazenil

Criteria

Please contact site for information.